Can a smartphone app lift teen depression?
NCT ID NCT07163013
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a mobile app called Moca, which delivers digital cognitive behavioral therapy (DCBT), can reduce depressive symptoms in Chinese adolescents aged 12 to 18. Two hundred teens with moderate to severe symptoms will use the app for weekly guided sessions. The goal is to see if the app is both effective and acceptable as a treatment option.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- digital cognitive behavioral therapy (DCBT) via a mobile app called Moca
- What this could lead to
- If it works, this could provide a scalable, accessible treatment option for depressed adolescents who might not otherwise get help.
- What could go wrong
- This is a relatively small, early-stage trial in one country, so results may not apply elsewhere. The app-based approach may not work for everyone, and some teens may need more intensive support.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age 12 to 18 years; 2. Scored 28 or higher on the children's depression rating scale-revised (CDRS-R); 3. Have the ability to read and write in Chinese; 4. Participant and at least one of their guardians provided written consent; 5. Have access to mobile phone and internet. Exclusion Criteria: 1. The researchers assessed that the adolescent's depressive symptoms were too severe to participate to CADS-D; 2. Scored 5 or higher on item 13 (suicidal ideation) on CDRS-R; 3. Participants who met diagnosis of other mental disorder except depression; 4. Severe physical illnesses or other physical disabilities that prevented the use of DCBT; 5. Within the past three months or currently undergoing any antidepressant treatment, including medication therapy, psychotherapy, and physical therapy; 6. Unavailability to follow up months after intervention.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depressive symptom are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, 400016, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Four-Session talk therapy course ease medical Students' anxiety?
- Breathing to beat blues: new study tests Music-Mindfulness combo for seniors
- Could a ketamine mist lift severe depression fast?
- Single dose of esketamine during surgery may ward off Post-Op depression in ovarian cancer patients
- New program aims to ease the emotional burden on dementia caregivers
- Smart coaching helps diabetics manage blood sugar